Armata Pharmaceuticals (ARMP) Research & Development (2016 - 2018)
Historic Research & Development for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to $2.0 million.
- Armata Pharmaceuticals' Research & Development rose 8201.83% to $2.0 million in Q4 2018 from the same period last year, while for Dec 2018 it was $7.3 million, marking a year-over-year increase of 9609.16%. This contributed to the annual value of $34.4 million for FY2024, which is 194.26% up from last year.
- According to the latest figures from Q4 2018, Armata Pharmaceuticals' Research & Development is $2.0 million, which was up 8201.83% from $1.9 million recorded in Q3 2018.
- Armata Pharmaceuticals' 5-year Research & Development high stood at $5.6 million for Q4 2016, and its period low was $41000.0 during Q3 2016.
- Moreover, its 5-year median value for Research & Development was $1.2 million (2015), whereas its average is $1.6 million.
- The largest annual percentage gain for Armata Pharmaceuticals' Research & Development in the last 5 years was 35687.24% (2016), contrasted with its biggest fall of 9436.81% (2016).
- Over the past 5 years, Armata Pharmaceuticals' Research & Development (Quarter) stood at $1.1 million in 2014, then increased by 9.16% to $1.2 million in 2015, then soared by 356.87% to $5.6 million in 2016, then tumbled by 80.36% to $1.1 million in 2017, then surged by 82.02% to $2.0 million in 2018.
- Its Research & Development stands at $2.0 million for Q4 2018, versus $1.9 million for Q3 2018 and $2.3 million for Q2 2018.